Prevalence of hepatitis D virus co-infection in Austria - Finding the needle in the haystack

Affiliations

¹ Departments of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
² Departments of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.

Editorial

Milan J Sonneveld et al. United European Gastroenterol J. 2021 Dec.

. 2021 Dec;9(10):1105-1106.

doi: 10.1002/ueg2.12177. Epub 2021 Nov 24.

¹ Departments of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
² Departments of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.

No abstract available

Conflict of interest statement

The authors declare no conflicts of interest.

Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis.
Jachs M, Binter T, Schmidbauer C, Hartl L, Strasser M, Laferl H, Hametner-Schreil S, Lindorfer A, Dax K, Stauber RE, Kessler HH, Bernhofer S, Maieron A, Loacker L, Bota S, Santonja I, Munda P, Mandorfer M, Peck-Radosavljevic M, Holzmann H, Gschwantler M, Zoller H, Ferenci P, Reiberger T. Jachs M, et al. United European Gastroenterol J. 2021 Dec;9(10):1119-1127. doi: 10.1002/ueg2.12163. Epub 2021 Dec 7. United European Gastroenterol J. 2021. PMID: 34873866 Free PMC article.

1. Jachs M, Binter T, Strasser M, Laferl H, Hametner‐Schreil S, Lindorfer A, et al. Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis. United European Gastroenterology Journal. 2021. - PMC - PubMed
1. European Association for the Study of the Liver . Electronic address eee, European Association for the Study of the L. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370–98. - PubMed
1. El Bouzidi K, Elamin W, Kranzer K, Irish DN, Ferns B, Kennedy P, et al. Hepatitis delta virus testing, epidemiology and management: a multicentre cross‐sectional study of patients in London. J Clin Virol. 2015;66:33–7. - PubMed
1. Palom A, Rodriguez‐Tajes S, Navascues CA, García‐Samaniego J, Riveiro‐Barciela M, Lens S, et al. Long‐term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia. Aliment Pharmacol Ther. 2020;51(1):158–166. - PubMed
1. Sonneveld MJ, de Knegt RJ. Editorial: rapid disease progression in hepatitis delta‐can we turn the tide? Aliment Pharmacol Ther. 2020;51(1):172–3. - PubMed